OPCH vs ZBH
Option Care Health vs Zimmer Biomet — AI-powered side-by-side comparison
OPCH
Option Care Health
69
Buy
VS
| Metric | OPCH | ZBH |
|---|
| AI Score |
69
|
69
|
| Price |
$23.95
|
$100.62
|
| P/E Ratio |
18.00×
|
24.37×
|
| ROE |
15.7%
|
5.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
18.2%
|
69.9%
|
| Debt / Equity |
1.01×
|
0.59×
|
| Dividend Yield |
0.0%
|
1.0%
|
| RSI (14) |
62.3
|
68.8
|
| Beta |
0.606
|
0.462
|
| Expected Upside |
+1.4%
|
+0.8%
|
AI Committee View
Current Innellis committee reasoning for OPCH versus ZBH.
The committee scores are tied.
OPCH and ZBH both score 69/100.
OPCH Committee View
60% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Bollinger bandwidth of 19.8% signals elevated volatility — Risk
ZBH Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend. The committee is constructive but not yet at full conviction.
Bull Case
- Price-to-book of 1.4x is a discount to asset value — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical